Kisspeptin-54 triggers egg maturation in women undergoing in vitro fertilization

Journal of Clinical Investigation

Volumn 124, Issue 8, 2014, Pages 3667-3677

  Jayasena, Channa N ^a   Abbara, Ali ^a   Comninos, Alexander N ^a   Nijher, Gurjinder M K ^a   Christopoulos, Georgios ^a   Narayanaswamy, Shakunthala ^a   Izzi Engbeaya, Chioma ^a   Sridharan, Mathini ^a   Mason, Alexina J ^b   Warwick, Jane ^b   Ashby, Deborah ^b   Ghatei, Mohammad A ^a   Bloom, Stephen R ^a   Carby, Anna ^a   Trew, Geoffrey H ^a   Dhillo, Waljit S ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CETRORELIX; GONADORELIN ANTAGONIST; LUTEINIZING HORMONE; METASTIN; RECOMBINANT FOLLITROPIN; FERTILITY PROMOTING AGENT; FOLLITROPIN; GONADORELIN; KISS1 PROTEIN, HUMAN; KISSPEPTIN; RECOMBINANT PROTEIN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; CONTROLLED STUDY; EMBRYO; EMBRYO TRANSFER; FEMALE; FEMALE SUBFERTILITY; FERTILIZATION IN VITRO; HUMAN; INTRACYTOPLASMIC SPERM INJECTION; LUTEINIZING HORMONE RELEASE; MAJOR CLINICAL STUDY; OOCYTE MATURATION; PREGNANCY RATE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE DRUG DOSE; SUPEROVULATION; ADVERSE EFFECTS; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DOSE RESPONSE; DRUG EFFECTS; GROWTH, DEVELOPMENT AND AGING; INFERTILITY; OOCYTE; OVULATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PREGNANCY; PREGNANCY, ECTOPIC; PROCEDURES;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FERTILITY AGENTS, FEMALE; FERTILIZATION IN VITRO; FOLLICLE STIMULATING HORMONE; GONADOTROPIN-RELEASING HORMONE; HUMANS; INFERTILITY; KISSPEPTINS; OOCYTES; OVULATION; PREGNANCY; PREGNANCY, ECTOPIC; RECOMBINANT PROTEINS;

EID: 84904494203     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI75730     Document Type: Article

References (50)

1. Ohtaki T, et al. Metastasis suppressor gene KiSS-1 encodes peptide ligand of a G-protein-coupled receptor. Nature. 2001;411(6837):613-617.
2. Kotani M, et al. The metastasis suppressor gene KiSS-1 encodes kisspeptins, the natural ligands of the orphan G protein-coupled receptor GPR54. J Biol Chem. 2001;276(37):34631-34636.
3. Muir AI, et al. AXOR12, a novel human G proteincoupled receptor, activated by the peptide KiSS-1. J Biol Chem. 2001;276(31):28969-28975.
4. de Roux N, Genin E, Carel JC, Matsuda F, Chaussain JL, Milgrom E. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54. Proc Natl Acad Sci U S A. 2003;100(19):10972-10976.
5. Seminara SB, et al. The GPR54 gene as a regulator of puberty. N Engl J Med. 2003;349(17):1614-1627.
6. Topaloglu AK, et al. Inactivating KISS1 mutation and hypogonadotropic hypogonadism. N Engl J Med. 2012;366(7):629-635.
7. Teles MG, et al. A GPR54-activating mutation in a patient with central precocious puberty. N Engl J Med. 2008;358(7):709-715.
8. Goodman RL, et al. Kisspeptin neurons in the arcuate nucleus of the ewe express both dynorphin A and neurokinin B. Endocrinology. 2007;148(12):5752- 5760.
9. Irwig MS, et al. Kisspeptin activation of gonadotropin releasing hormone neurons and regulation of KiSS-1 mRNA in the male rat. Neuroendocrinology. 2004;80(4):264-272.
10. Clarkson J, Herbison AE. Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropinreleasing hormone neurons. Endocrinology. 2006;147(12):5817-5825.
11. Han SK, et al. Activation of gonadotropin-releasing hormone neurons by kisspeptin as a neuroendocrine switch for the onset of puberty. J Neurosci. 2005;7(25):11349-11356.
12. Navarro VM, et al. Developmental and hormonally regulated messenger ribonucleic acid expression of KiSS-1 and its putative receptor, GPR54, in rat hypothalamus and potent luteinising hormone-releasing activity of KiSS-1 peptide. Endocrinology. 2004;145(10):4565-4574.
13. Gottsch ML, et al. A role for kisspeptins in the regulation of gonadotropin secretion in the mouse. Endocrinology. 2004;145(9):4073-4077.
14. Messager S, et al. Kisspeptin directly stimulates gonadotropin-releasing hormone release via G protein-coupled receptor 54. Proc Natl Acad Sci U S A. 2005;102(5):1761-1766.
15. Shahab M, Mastronardi C, Seminara SB, Crowley WF, Ojeda SR, Plant TM. Increased hypothalamic GPR54 signaling: a potential mechanism for initiation of puberty in primates. Proc Natl Acad Sci U S A. 2005;102(6):2129-2134.
16. Caraty A, et al. Kisspeptin synchronizes preovulatory surges in cyclical ewes and causes ovulation in seasonally acyclic ewes. Endocrinology. 2007;148(11):5258-5267.
17. Dhillo WS, et al. Kisspeptin-54 stimulates the hypothalamic-pituitary- gonadal axis in human males. J Clin Endocrinol Metab. 2005;90(12):6609-6615.
18. Dhillo WS, et al. Kisspeptin-54 stimulates gonadotropin release most potently during the preovulatory phase of the menstrual cycle. J Clin Endocrinol Metab. 2007;92(10):3958-3966.
19. Chan YM, et al. Kisspeptin resets the hypothalamic GnRH clock in men. J Clin Endocrinol Metab. 2011;96(6):E908-E915.
20. George JT, et al. Kisspeptin is a potent stimulator of LH and increases pulse frequency in men. J Clin Endocrinol Metab. 2011;96(8):E1228-E1236.
21. Chan YM, Butler JP, Sidhoum VF, Pinnell NE, Seminara SB. Kisspeptin administration to women: a window into endogenous kisspeptin secretion and GnRH responsiveness across the menstrual cycle. J Clin Endocrinol Metab. 2012;97(8):E1458-E1467.
22. Young J, et al. Kisspeptin restores pulsatile LH secretion in patients with neurokinin B signaling deficiencies: physiological, pathophysiological and therapeutic implications. Neuroendocrinology. 2013;97(2):193-202.
23. Jayasena CN, et al. Subcutaneous injection of kisspeptin-54 acutely stimulates gonadotropin secretion in women with hypothalamic amenorrhea but chronic administration causes tachyphylaxis. J Clin Endocrinol Metab. 2009;94(11):4315-4323.
24. Jayasena CN, et al. Twice-daily subcutaneous injection of kisspeptin-54 does not abolish menstrual cyclicity in healthy female volunteers. J Clin Endocrinol Metab. 2013;98(11):4464-4474.
25. Roseweir AK, et al. Discovery of potent kisspeptin antagonists delineate physiological mechanisms of gonadotropin regulation. J Neurosci. 2009;29(12):3920-3929.
26. Inoue N, et al. Kisspeptin neurons mediate reflex ovulation in the musk shrew (Sunsus murinus). Proc Natl Acad Sci U S A. 2011;108(42):17527-17532.
27. Clarkson J, d'Anglemont de Tassigny X, Moreno AS, Colledge WH, Herbison AE. Kisspeptin-GPR54 signaling is essential for preovulatory gonadotropin-releasing hormone neuron activation and the luteinizing hormone surge. J Neurosci. 2008;28(35):8691-8697.
28. Matsui H, Takatsu Y, Kumano S, Matsumoto H, Ohtaki T. Peripheral administration of metastin induces marked gonadotropin release and ovulation in the rat. Biochem Biophys Res Commun. 2004;320(2):383-388.
29. Smith JT, Popa SM, Clifton DK, Hoffman GE, Steiner RA. Kiss1 neurons in the forebrain as central processors for generating the preovulatory luteinising hormone surge. J Neurosci. 2006;26(25):6687-6694.
30. Jayasena CN, et al. The effects of kisspeptin-10 on reproductive hormone release show sexual dimorphism in humans. J Clin Endocrinol Metab. 2011;96(12):E1963-E1972.
31. Macklon NS, Stouffer RL, Giudice LC, Fauser BC. The science behind 25 years of ovarian stimulation for in vitro fertilization. Endocr Rev. 2006;27(2):170-207.
32. Coulam CB, Bustillo M, Schulman JD. Empty follicle syndrome. Fertil Steril. 1986;46(6):1153-1155.
33. Horikoshi Y, et al. Dramatic elevation of plasma metastin concentrations in human pregnancy: metastin as a novel placenta-derived hormone in humans. J Clin Endocrinol Metab. 2003;88(2):914-919.
34. Shufaro Y, Laufer N. Epigenetic concerns in assisted reproduction: update and critical review of the current literature. Fertil Steril. 2013;99(3):605-606.
35. Chang HJ, Suh CS. Ectopic pregnancy after assisted reproductive technology: what are the risk factors? Curr Opin Obstet Gynecol. 2010;22(3):202-207.
36. Malak M, Tawfeeq T, Holzer H, Tulandi T. Risk factors for ectopic pregnancy after in vitro fertilization treatment. J Obstet Gynaecol Can. 2011;33(6):617-619.
37. Dubuisson JB, Aubriot FX, Mathieu L, Foulot H, Mandelbrot L, de Jolière JB. Risk factors for ectopic pregnancy in 556 pregnancies after in vitro fertilization: implications for preventive management. Fertil Steril. 1991;56(4):686-690.
38. Damewood MD, Shen W, Zacur HA, Schlaff WD, Rock JA, Wallach EE. Disappearance of exogenously administered human chorionic gonadotropin. Fertil Steril. 1989;52(3):398-400.
39. Golan A, Ron-el R, Herman A, Soffer Y, Weinraub Z, Caspi E. Ovarian hyperstimulation syndrome: an update review. Obstet Gynecol Surv. 1989;44(6):430-440.
40. Fauser BC, et al. Endocrine profiles after triggering of final oocyte maturation with GnRH agonist after cotreatment with the GnRH antagonist ganirelix during ovarian hyperstimulation for in vitro fertilization. J Clin Endocrinol Metab. 2002;87(2):709-715.
41. Humaidan P, Kol S, Papanikolaou EG, Copenhagen GnRH Agonist Triggering Workshop Group. GnRH agonist for triggering of final egg maturation: time for a change of practice? Hum Reprod Update. 2011;17(4):510-524.
42. Humaidan P, et al. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study. Hum Reprod. 2005;20(5):1213-1220.
43. Beckers NG, et al. Nonsupplemented luteal phase characteristics after the administration of recombinant human chorionic gonadotropin, recombinant luteinizing hormone, or gonadotropinreleasing hormone (GnRH) agonist to induce final oocyte maturation in in vitro fertilization patients after ovarian stimulation with recombinant follicle-stimulating hormone and GnRH antagonist cotreatment. J Clin Endocrinol Metab. 2003;88(9):4186-4192.
44. Enien WM, Chantler E, Seif MW, Elstein M. Human ovarian granulosa cells and follicular fluid indices: the relationship to oocyte maturity and fertilization in vitro. Hum Reprod. 1998;13(5):1303-1306.
45. Revelli A, Delle Piane L, Casano S, Molinari E, Massobrio M, Rinaudo P. Follicular fluid content and oocyte quality: from single biochemical markers to metabolomics. Reprod Biol Endocrinol. 2009;7:40.
46. Rattanachaiyanont M, Leader A, Léveillé MC. Lack of correlation between oocyte-coronacumulus complex morphology and nuclear maturity of oocytes collected in stimulated cycles for intracytoplasmic sperm injection. Fertil Steril. 1999;71(5):937-940.
47. DiLuigi AJ, Nulsen JC. Effects of gonadotropinreleasing hormone agonists and antagonists on luteal function. Curr Opin Obstet Gynecol. 2007;19(3):258-265.
48. Felberbaum RE, et al. Preserved pituitary response under ovarian stimulation with HMG and GnRH antagonists (Cetrorelix) in women with tubal infertility. Eur J Obstet Gynecol Reprod Biol. 1995;61(2):151-155.
49. Cutting R, Morroll D, Roberts SA, Pickering S, Rutherford A, BFS ACE. Elective single embryo transfer: guidelines for practice British Fertility Society and Association of Clinical Embryologists. Hum Fertil (Camb). 2008;11(3):131-146.
50. Gardner DK, Lane M, Stevens J, Schlenker T, Schoolcraft WB. Blastocyst score affects implantation and pregnancy outcome: towards a single blastocyst transfer. Fertil Steril. 2000;73(6):1155-1158.